Barry D. Quart, Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 100,000 shares at $24.75 ($2.5M) on 2018-03-14, disclosed to the SEC on 2018-03-16.
Open-market sale of $2.5M HRTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |